Epilepsy Therapeutics Market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Epilepsy</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
<strong>Epilepsy</strong> is a chronic neurological disorder characterized by unpredictable seizures. <strong>Epilepsy</strong> is<br />
the fourth most common neurological disorder that affects peoples of all age group. Seizures<br />
may be classified as focal seizures, generalized seizures, and other seizures. Focal seizures are<br />
the most common type of epilepsy which involves secondary generalized tonic/clonic seizures<br />
(sGTCS) and complex partial seizures. Generalized seizures include myoclonic seizures, tonic<br />
seizures, atonic seizures, absences, and clonic seizures. These seizures occur when neurons in<br />
the brain or a group of nerve cells send wrong signals to the body.<br />
Browse the full " <strong>Epilepsy</strong> <strong>Therapeutics</strong> <strong>Market</strong>" report<br />
at https://www.zionmarketresearch.com/report/epilepsy-therapeutics-market<br />
Treatment of epilepsies is done by using antiepileptic drugs (AEDs). Antiepileptic drugs are<br />
segmented into two major categories namely first generation AEDs and second generation<br />
AEDs. Selection of drugs is done by prescriber depending upon the type of seizure, part of brain<br />
involved in epilepsy, age of patient.
Change language